Rizzardini G, Overton ET, Orkin C, Swindells S, et al. Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials. J Acquir Immune Defic Syndr 2020;85:498-506.
PMID: 33136751